Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03851601 · ClinicalTrials.gov registry record
Immuno-regulatory Profiling of T Cells in GVHD Treated With Extracorporeal Photopheresis
A clinical trial, sponsored by Henry Ford Health System.
- Completed
- Registry status
- 6
- Enrollment target
NCT03851601 is a clinical trial that has completed, run by Henry Ford Health System. The registered enrollment target is 6 participants.
The verdict
NCT03851601 has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- 6 participants
- Enrollment target
Study Summary
Extracorporeal Photopheresis (ECP) has been used as one of the treatments for graft versus host disease (GVHD). Responses were observed in skin, liver, GI tract, mouth, eye and lung. ECP does not cause immune suppression and therefore less risk of infection or relapse of malignancy. However, the exact mechanism of action of this expensive procedure is not fully understood and no predictors of response to ECP are known so far. This reflects the need for a better understanding of GVHD and its response to ECP. Blood samples from 15 patients who receive ECP as part of the treatment of GVHD at our institution will be collected. Samples will be analyzed using flow cytometer
Interventions
- OTHER blood samples
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2014-08-26 |
| Est. Completion | 2023-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03851601
The ClinicalTrials.gov registry entry for NCT03851601 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which blood samples is the first listed.
NCT03851601 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03851601 about?
NCT03851601 is a clinical study titled "Immuno-regulatory Profiling of T Cells in GVHD Treated With Extracorporeal Photopheresis". Extracorporeal Photopheresis (ECP) has been used as one of the treatments for graft versus host disease (GVHD). Responses were observed in skin, liver, GI tract, mouth, eye and lung. ECP does not cause immune suppression and therefore less risk of infection or relapse of malignancy. However, the exa...
What is the current status of trial NCT03851601?
This trial is currently completed. The enrollment target is 6 participants. The study started on 2014-08-26. Estimated completion is 2023-06-30.
What interventions are being tested in trial NCT03851601?
The interventions under investigation include: blood samples (OTHER).
Who is sponsoring clinical trial NCT03851601?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.